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Ian S. Rogers, MD, MPH, Khurram Nasir, MD, MPH, Amparo L. Figueroa, MD,
Ricardo C. Cury, MD, Udo Hoffmann, MD, MPH, David A. Vermylen, BS,
Thomas J. Brady, MD, Ahmed Tawakol, MD
Boston, Massachusetts
O B J E C T I V E S This study tested the hypothesis that ﬂuorodeoxyglucose (FDG) uptake within the
ascending aorta and left main coronary artery (LM), measured using positron emission tomography
(PET), is greater in patients with recent acute coronary syndrome (ACS) than in patients with stable
angina.
B A C KG ROUND Inﬂammation is known to play an important role in atherosclerosis. Positron
emission tomography imaging with 18F-FDG provides a measure of plaque inﬂammation.
METHOD S Twenty-ﬁve patients (mean age 57.9  9.8 years, 72% male, 10 ACS, and 15 stable
angina) underwent cardiac computed tomographic angiography and PET imaging with 18F-FDG after
invasive angiography. Images were coregistered, and FDG uptake was measured at locations of interest
for calculation of target-to-background ratios (TBR). Additionally, FDG uptake was measured at the site
of the lesion deemed clinically responsible for the presenting syndrome (culprit) by virtue of locating the
stent deployed to treat the syndrome.
R E S U L T S The FDG uptake was higher in the ACS versus the stable angina groups in the ascending
aorta (median [interquartile ranges] TBR 3.30 [2.69 to 4.12] vs. 2.43 [2.00 to 2.86], p  0.02), as well as
the LM (2.48 [2.30 to 2.93] vs. 2.00 [1.71 to 2.44], p  0.03, respectively). The TBR was greater for culprit
lesions associated with ACS than for lesions stented for stable coronary syndromes (2.61 vs. 1.74, p  0.02).
Furthermore, the TBR in the stented lesions (in ACS and stable angina groups) correlated with C-reactive
protein (r  0.58, p  0.04).
CONC L U S I O N S This study shows that in patients with recent ACS, FDG accumulation is increased
both within the culprit lesion as well as in the ascending aorta and LM. This observation suggests
inﬂammatory activity within atherosclerotic plaques in acute coronary syndromes and supports
intensiﬁcation of efforts to reﬁne PET methods for molecular imaging of coronary plaques. (J Am Coll
Cardiol Img 2010;3:388–97) © 2010 by the American College of Cardiology Foundation
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389he majority of myocardial infarctions (MI)
and sudden cardiac deaths result from the
rupture of plaques that in most cases did not
cause significant flow limitations before the
cute event (1,2). Although stenosis severity has
roven a poor predictor of plaque rupture (3),
everal other plaque characteristics, notably plaque
nflammation, have been strongly associated with
laque rupture and thrombosis (4–7). Imaging with
uorodeoxyglucose (FDG) positron emission to-
ography (PET) provides a reproducible measure
f glycolysis (8), which has proven invaluable for
he identification of small, metabolically active tis-
ues such as tumors and inflamed lesions (9).
urthermore, FDG accumulation has been shown
o provide an index of atherosclerotic inflammation,
s demonstrated in animal models and humans
10–12). Several studies have shown that FDG activity
ithin plaques correlates with inflammation in athero-
clerosis (13–15). Furthermore, the vascular PET signal
s reproducible (16,17) and is modifiable by interventions
hat have an anti-inflammatory effect (18).
Prior investigators have reported FDG accumula-
ion in association with coronary vessels (19–22).
owever, the lack of a standard for coronary inflam-
ation within those studies provided little evidence
hat the FDG uptake was related to plaque activity.
everal factors impart formidable obstacles to coronary
DG PET imaging, including uptake of FDG by
djacent myocardium, the limited spatial resolution of
ET, and the substantial motion of the coronary
rteries. In the present study, we attempted to deter-
ine whether FDG uptake can be measured in the
scending aorta and in the relatively immobile left
ain coronary artery (LM) despite the known obsta-
les and whether the signal is increased in patients
resenting with acute coronary syndrome (ACS).
oreover, we sought to test the hypothesis that FDG
ptake is greatest within lesions that are expected to be
nflamed: those plaques that are deemed to have
ecently caused an ACS. We took advantage of
oncurrent computed tomographic (CT) angiography
or delineation of coronary activity and to identify the
laques associated with stents that were deployed to
reat ACS. We sought to test the hypothesis that
DG uptake within plaques locations deemed respon-
ible for ACS is greater than in remotely stented
laques, which are presumably less inflamed. Addi-
ionally, to exclude FDG uptake secondary to lesion
anipulation, we compared FDG uptake in plaques
ecently stented for ACS with plaques recently stented
or stable coronary syndromes. cETHODS
atients. The study was performed in 25 patients
average age 58  10 years, 72% men), 10 of whom
resented with ACS requiring stent placement
ACS, n  10). Of the remaining 15 patients with
table angina (n  15), 5 presented with stable
ngina requiring stent placement (n  5) and 10
resented with atypical or typical chest pain for
hich a coronary angiographic evaluation was re-
uired in the clinical judgment of the referring
hysicians. All subject cases were adjudicated for
tudy group classification after eligibility determi-
ation and receiving informed consent. Subjects
ere classified as having experienced ACS
i.e., ST-segment elevation MI [n  1],
on–ST-segment elevation MI [n  4],
r unstable angina [n  5]) or as hav-
ng experienced stable angina (n  15)
ased on the nature and chronicity of their
hest pain, medical history, and available
iagnostics (such as electrocardiograms
ECGs] and biomarkers), according to the
merican College of Cardiology/American
eart Association guideline definitions (23),
nd as supported by findings on coronary
rteriography.
Patients were not eligible if they had
iabetes mellitus, an allergy to iodinated
ontrast, renal dysfunction, hemodynamic
nstability, substantial arrhythmias, or de-
ompensated heart failure. The study proto-
ol was approved by the human research
ommittee at the Massachusetts General
ospital, and informed consent was ob-
ained from each subject.
atient preparation. After catheterization,
ubjects underwent cardiac CT angiogra-
hy and cardiac FDG PET imaging. To
inimize myocardial glucose uptake in order to
etter visualize coronary FDG uptake, we took
dvantage of the myocardium’s preference for free
atty acid over glucose as an energy source. On the
ay before imaging, subjects were asked to adhere
o a very-low-carbohydrate, high-fat diet and then
o fast overnight (24), followed by the administra-
ion of a high-fat, low-carbohydrate beverage 45
in before FDG injection (approximately 150 ml
tkins Advantage Shake, Atkins Nutritionals,
onkonkoma, New York).
ET imaging. The PET imaging was performed 3 h
fter administration of 13 mCi of 18F-FDG. The
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39016,25). Despite the widespread availability of PET
T systems, we used a dedicated PET system
Siemens ECAT Exact HR, Knoxville, Tennes-
ee) to avoid the potential misregistration that can
ccur when CT attenuation maps are used to
orrect the PET volume data. The system provides
3 planes, a 15.5-cm field of view, and a maximum
.2-mm intrinsic resolution at the center of the field
f view. Data were acquired in 2-dimensional mode
ver 25 min, with subjects in the supine position.
mage data were attenuation-corrected using PET
ransmission data; reconstructed using a conven-
ional, filtered back-projection algorithm; and cor-
ected for nonuniformity of detector responses,
ead time, random coincidences, and scattered
adiation.
ardiac CT imaging. The CT imaging was performed
n the same day as PET acquisition (Siemens Sensa-
ion 64, Forchheim, Germany). Subjects were pre-
edicated with intravenous metoprolol and sublin-
ual nitroglycerin unless medically contraindicated.
maging was performed during an inspiratory
reath hold, and ECG-triggered tube current mod-
lation was used to reduce radiation exposure.
arameters included a slice collimation of 64  0.6
m, temporal resolution of 165 ms, tube voltage of
20 kVp, and tube current of 850 mAs. Images
ere retrospectively gated to the ECG and recon-
tructed at 65% of the R-R interval using a
edium-smooth kernel and slice thickness/
ncrement of 0.75/0.4 mm.
easurement of FDG uptake. The PET images were
anually coregistered with CT images (Leonardo
rueD, Siemens Forchheim, Germany) by an in-
estigator who was blinded to the patients’ clinical
istory and classification. Perfect coregistration of
hest structures between the PET and CT images
as not feasible given the differences in cardiovas-
ular and respirophasic motion affecting the major
tructures within the PET images (which were
cquired over 25 min of free breathing) and the CT
which was ECG gated and acquired during a
reath hold). Accordingly, we used a strategy of
rioritizing the registration of the ascending aorta
iven that it is discernable on both PET and CT
mage sets and that its proximity to the tethered
M increases the likelihood of excellent LM coreg-
stration in turn.
Once coregistered, the maximum standardized
ptake value (SUV) of FDG was measured within
he ascending aorta and within several pre-defined
oronary locations. To accomplish this, CT images
ere used to guide placement of 5-mm2 regions of jnterest (ROIs) over the vascular segment being
easured and the maximum SUV value within each
OI was recorded. First, measurement of aortic
ctivity was acquired as the average of 6 ROIs
laced along the wall of the ascending aorta 20 mm
bove the aortic annulus. Next, SUV measurements
ere obtained in several pre-defined coronary loca-
ions in all subjects: the LM, the proximal and
id–left anterior descending (LAD), the left cir-
umflex artery (LCx), and the right coronary artery
RCA). Activity in the LM was measured approx-
mately 8 mm from the LM ostium to avoid
pillover of activity from the aorta. Activity in the
roximal and mid-LAD and LCx was measured
pproximately 8 and 16 mm from the bifurcation or
rifurcation, and activity in the proximal and mid-
CAwas measured approximately 8 and 16 mm from
he RCA ostium. Next, FDG uptake was measured at
he site of the culprit coronary lesion, which was
efined as the coronary segment deemed by the
linical team to be responsible for the syndrome, for
hich a stent was deployed at presentation. The
ulprit lesion was in turn identified on the CT
mages by locating the stent. The ROI was placed at
he location of highest plaque activity overlying the
tent, and the maximum SUV was recorded.
To obtain a background value for FDG uptake,
lood SUV was determined by placement of 6
-cm3 ROIs within the left atrial cavity in locations
evoid of significant spillover activity. The mean
UV value for each ROI was measured and the
verage of the 6 arterial values was recorded. After-
ard, a target-to-background ratio (TBR) was cal-
ulated for each vascular segment measured as the
egment maximum SUV divided by atrial blood
ean SUV.
Suppression of myocardial FDG uptake was
ssessed according to the qualitative visual grading
cale proposed by Williams and Kolodny (24): 0 
inimal uptake; 1  mostly minimal or mild
ptake; 2mostly intense or moderate uptake; 3
omogeneously intense.
To evaluate interobserver reliability of the coreg-
stration and measurement process, images from 10
andomly selected patients were independently
oregistered by 2 investigators (A.T., I.R.) on 2
eparate occasions. The investigators were blinded
o all information regarding the case, including
linical history and group classification of each
ubject. Aortic and coronary measurements were
epeated as previously described.
lood biomarkers. Blood was collected from sub-
ects on the day of imaging before FDG injection or
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391mage acquisition. Several inflammatory biomarkers
ere measured, including high-sensitivity C-reactive
rotein (CRP), CD40, intercellular adhesion
olecule-1, interleukin-12 p70 (IL-12 p70), tumor
ecrosis factor-alpha, immunoglobulin M, and vas-
ular cell adhesion molecule-1, via multiplexed
mmunoassay (Rules-Based Medicine, Inc., Austin,
exas).
tatistical methods. Analysis of the baseline charac-
eristics of the ACS and stable groups was con-
ucted through the use of t tests for normal con-
inuous variables, Wilcoxon rank sum tests for
onnormal continuous variables, and Fisher exact
ests for binary variables. The TBR data are pre-
ented as median and interquartile range (IQR),
nd the differences between the groups were as-
essed by Wilcoxon rank sum tests. Correlations are
eported as Spearman correlation coefficients. Intra-
lass correlation coefficients were calculated to de-
ermine interobserver reliability using the mean
UV values obtained by the readers during the
eliability analysis. All analyses were performed
ith SAS (version 9.1, SAS Institute, Inc., Cary,
orth Carolina). A value of p  0.05 was consid-
red significant.
E SULTS
emographic information regarding the enrolled
atients are summarized in Table 1. The PET/CT
xamination was performed within a median of 8
Table 1. Baseline Characteristics of the Subjects
ACS G
(n 
Age (yrs) 55.7
Male sex (%) 7
History of CAD (%) 2
Family history of CV disease 60 yrs (%) 1
Total cholesterol (mg/dl) 186
HDL cholesterol (mg/dl) 47.1
LDL cholesterol (mg/dl) 102.7
Triglycerides (mg/dl) 171
Statin use (%) 7
Systolic blood pressure (mm Hg) 125.8
Hypertension (%) 8
Antihypertensive therapy (%) 8
Current smoking (%) 5
Body mass index (kg/m2) 27.4
Framingham risk score 10.3
Continuous values are presented as mean  SD. Binary values are presented a
2-sample Student t tests (continuous values) and Fisher exact tests (binary valu
ACS  acute coronary syndrome; CAD  coronary artery disease; CV  cardiovascays (IQR 3 to 21 days) in patients with recent
tent placement for ACS and within a median of 16
ays (IQR 8 to 22 days) in patients with recent
tent placement for stable angina. The difference in
ime from stent placement between groups was not
ignificant (p  0.62).
yocardial FDG suppression and image quality. Myo-
ardial uptake of FDG was minimal in 10 of 25
40%) subjects, mostly minimal or mild in 11 of 25
44%) subjects, mostly intense or moderate in 3 of
5 (12%) subjects, and homogeneously intense in 1
4%) subject. There was no difference in the degree
f myocardial uptake among subject groups (p  0.93).
n the 25 patients studied, 100% (25) of ascending
ortas and left main segments were evaluable. A
otal of 175 total coronary segments were investi-
ated, 96% (168 of 175) of which were evaluable by
ET. Seven segments (4%) could not be evaluated
ecause of spillover of adjacent myocardial uptake.
he blinded interobserver reliability analysis for the
oregistration process revealed intraclass correlation
oefficients between readers of 0.92 in the ascend-
ng aorta, 0.97 in the LM, 0.84 in the proximal
AD, 0.99 in the proximal LCx, and 0.29 in the
roximal RCA.
ascular FDG accumulation. CULPRITLESIONACTIVITY.
nalysis of the PET signal within stented lesions
as feasible in 89% (24 of 27) of all stented lesions,
ncluding 8 of 10 in the ACS group and 16 of 17 in
he stable angina group (Table 2). The PET signal
given as median TBR [IQR]) within the culprit
p
)
Stable Group
(n  15) p Value*
.1 58.5 10.1 0.50
73.3 1.00
66.7 0.04
46.7 0.09
.6 172 36.7 0.37
.7 44 10.7 0.53
.2 100.4 31.5 0.86
.5 154.8 102.6 0.62
73.3 1.00
.4 128.13 17.5 0.76
93.3 0.54
93.3 0.54
20 0.19
5 30.9 4.2 0.04
4 6.5 6.8 0.23
centages. *p values for statistical difference between groups are calculated byrou
10
10
0
0
0
40
13
32
90
0
19
0
0
0
3.
8.
s per
es).ular; HDL  high-density lipoprotein; LDL  low-density lipoprotein.
Table 2. Summary of Subject Presentation and TBR Measurements
Age (yrs) Sex Clinical Presentation
TBR
Ascending Aorta Left Main Proximal LAD Proximal LCx Proximal RCA Recent Stent Remote Stent
ACS
38 F UAP: accelerating CP with anterior
T-wave inversions
     
60 M NSTEMI: accelerating angina, CP at rest      
43 M UAP: CP at rest with ECG changes      *
51 F NSTEMI: acute-onset CP at rest      
65 M UAP: CP radiating to left arm with
ST-segment depressions
     
53 M UAP: new-onset exertional CP with
minimal exertion
  *   
59 F STEMI: acute tent thrombosis 1 week
after BMS placement.
  *   
62 M UAP: acute-onset CP with minimal
exertion
  *   
69 M NSTEMI: acute-onset CP at rest      
63 M NSTEMI: acute-onset CP at rest      *
Stable angina requiring PCI
43 M CP syndrome over several months      
55 M CP syndrome over several months       —
50 F CP syndrome over several months      * 
65 M CP syndrome over several months       
78 M CP syndrome over several months      
Stable angina not requiring PCI
55 F Cardiomyopathy, no signiﬁcant stenosis     
56 M Stable CP: medical management of CAD      
58 F Stable CP: medical management of CAD     
74 F Remote MI, new CP; no new stenosis      
57 M Stable CP: medical management of CAD     
46 M Recent-onset CP; mild CAD on
catheterization
    
64 M Stable CP: medical management of CAD      
50 M Stable CP: medical management of CAD      
66 M Stable CP: medical management of CAD     
67 M Stable CP: medical management of CAD      
  TBR 1;   TBR 1.00 to 1.99;   TBR 2.0 to 2.99;   TBR 3.0 to 3.99;   TBR of 4.0 or greater. *Segment excluded due to spillover or location.
CP  chest pain; ECG  electrocardiogram; LAD  left anterior descending coronary artery; LCx  left circumﬂex coronary artery; MI myocardial infarction; NSTEMI  non–ST-segment elevation myocardial infarction; PCI  percutaneous coronary
infusion; RCA  right coronary artery; STEMI  ST-segment elevation myocardial infarction; TBR  target-to-background ratio; UAP  unstable angina pectoris; other abbreviations as in Table 1.
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393esions in patients with ACS (2.61 [2.27 to 3.45])
as higher than in stable angina patients (1.74
1.14 to 2.0], p  0.02) (Figs. 1 and 2). In contrast,
here was no significant difference in plaque activity
etween newly stented stable angina plaques and
emotely stented plaques (p  0.49). Additionally,
laque TBR was significantly higher within the
ulprit lesions of patients presenting with ACS than
ithin the proximal vessels of these same patients
2.61 [2.27 to 3.45] vs. 1.88 [1.3 to 2.4], p  0.04).
Of the 8 culprit lesions evaluated in ACS, 5
eceived bare-metal stents and 3 received drug-
luting stents. Of the 16 stented segments in the
table angina group, 6 received bare-metal stents
nd 10 received drug-eluting stents. There was no
ifference in TBR between plaques stented with
are-metal stents versus drug-eluting stents in the
CS group (p 0.70) or among all subjects (p 0.55).
imilarly, there was no correlation between TBR
nd: 1) stent diameter in either the ACS group
Spearman r  0.08, p  0.86) or among all
ubjects (r0.02, p 0.95); or 2) stent length in
ither the ACS group (r  0.39, p  0.39) or
Figure 1. Coregistered FDG PET/CT Images Show FDG Uptake W
Arrows show stent locations. Hatched arrows show lesions within t
a subject presenting with ACS. (B) More modest uptake in a corona
(some FDG uptake is also noted in a mixed plaque within the LM).
imaging. (D) The FDG uptake at the trifurcation of the LM in a subj
puted tomography; FDG  ﬂuorodeoxyglucose; LM  left main cormong all subjects (r  0.31, p  0.17). mther vascular activity. The PET signal within the
scending aorta was higher in subjects presenting
ith ACS versus stable angina (values given as
edian TBR [IQR]) (3.30 [2.73 to 4.0] vs. 2.43
2.00 to 2.9], p 0.02). Examples of a subject with
ncreased FDG uptake in the ascending aorta are
hown in Figure 3. Similarly, the PET signal was
ignificantly greater within the LM of subjects
resenting with ACS versus stable angina (2.48
2.30 to 2.93] vs. 2.00 [1.71 to 2.44], p  0.03)
Fig. 4). Although the signal within the proximal
nd mid-LAD segments was higher in ACS versus
table groups (2.20 vs. 1.75 and 1.50 vs. 1.0, p  0.03
nd p  0.04, respectively), the signals in the
roximal LCx and proximal RCA were not signif-
cantly different between the 2 groups (2.00 vs. 1.75
nd 2.17 vs. 1.60, for median TBR in ACS vs.
table angina in LCx and RCA, p  0.30 and p 
.059, respectively).
lood biomarkers. Subjects with ACS had a higher
lood level of log high-sensitivity CRP and IL-12
70 than stable angina subjects (p  0.02 and p 
.02, respectively). Moreover, several blood inflam-
n Speciﬁed Coronary Vascular Locations
LM. (A) Increased uptake in both LM and stented culprit lesions in
sion that was recently stented for a stable coronary syndrome
Modest FDG uptake within a lesion stented several months before
presenting with ACS. ACS  acute coronary syndrome; CT  com-
ry artery; PET  positron emission tomography.ithi
he
ry le
(C)
ectatory biomarkers correlated with the activity mea-
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394ured within stented segments. The TBR in the
laques treated for ACS or stable angina correlated
ith levels of CRP (r  0.58, p  0.04), immuno-
lobulin M (r  0.77, p  0.002), IL-12 p70 (r 
.62, p  0.02), and tumor necrosis factor- (r 
.56, p  0.048).
I SCUS S ION
ithin this feasibility study, we found for the first
ime that FDG uptake in the ascending aorta and
Figure 2. Box Plot Comparison of Interquartile Ranges of TBRs
The median TBR within the culprit lesions of subjects with ACS (2.6
prit lesions in stable angina subjects (1.74) and signiﬁcantly higher
subjects (1.43). There was no signiﬁcant difference in median TBR b
plaques (p  0.49). ACS  acute coronary syndrome; TBR  target
Figure 3. FDG Uptake in ACS
Coregistered FDG PET/CT images show increased FDG uptake in
the ascending aorta and in a culprit plaque in the LAD (arrow) in a
60-year-old man who presented with ACS. LAD  left anteriorb
descending coronary artery; other abbreviations as in Figure 1.M is increased in patients with ACS compared
ith patients with stable angina. Furthermore, we
ound that FDG uptake is greater in lesions judged
o be responsible for ACS compared with lesions
ssociated with stable coronary syndromes.
The correlation of 18F-FDG uptake and athero-
clerotic inflammation has been previously demon-
trated in animal and human studies. Studies in
umans show that FDG uptake correlates strongly
ith plaque inflammation (20) and that the mea-
urement of atherosclerotic FDG signal is highly
eproducible with intraclass correlation coefficients
etween 0.90 and 0.98 in medium to large arteries
16). Furthermore, the plaque signal is modifiable,
s demonstrated in animal models and clinical trials
18,26–28). Consistent with the concept that ACS
s associated with an enhanced inflammatory mi-
ieu, we found that FDG uptake in the ascending
orta was greater in patients presenting with ACS
han in stable angina patients. Similarly, we ob-
erved an increase in the PET signal within the LM
f patients presenting with ACS.
One important prior obstacle to demonstrating
easibility coronary plaque imaging with PET had
een the lack of a standard to support the conten-
ion that the observed hot spots were indeed derived
rom coronary plaques. In this study, we developed
reference point for clinically significant (culprit)
esions with a position that is conveniently marked
tented Plaques Among Study Groups
as signiﬁcantly higher (p  0.02) than the median TBR within cul-
0.006) than within previously stented plaques in stable angina
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395ulprit lesion at the time of catheterization. We
ound that FDG uptake within culprit lesions ACS,
hich as a group are known to substantially in-
amed (29), was significantly higher than within
table angina plaques. Furthermore, a significant
ifference remained when activity within recently
tented stable angina plaques and remotely stable
ngina plaques were compared, suggesting that the
ncreased signal observed in ACS was related to the
nderlying inflammation and not solely a conse-
uence of vascular injury after stent placement.
To minimize the impact of coronary motion on
ur image analysis, we prioritized the coregistration
f the ascending aorta, which conveniently tends to
how increased FDG uptake (16,30) in patients
ith atherosclerosis. Coregistration of the ascend-
ng aorta in turn yielded excellent registration of the
roximal coronary tree. Additionally, we directed
ur attention to the LM, which is tethered to the
orta and has a nonepicardial location, thus it
xperiences less motion within the cardiac cycle
31) and is less susceptible to interference by myo-
ardial FDG uptake. Even in cases of excellent
yocardial suppression of FDG activity, enough
esidual activity remained to permit registration of
he cardiac structures. It should be noted that ECG
ating of the PET acquisition was initially at-
empted in the development of this protocol but
as not ultimately used because in our experience
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Figure 4. Box Plot Comparison of Interquartile Ranges of TBRs
The median TBR within the ascending aorta of subjects with ACS (3.30
angina subjects (2.43). The median TBR within the LM of subjects with
stable angina subjects (2.00). Horizontal lines are medians, ends of
of data values. LM  left main coronary artery; other abbreviationshe loss of PET data associated with gating offset its sdvantage of reduced motion. However, we believe
hat refinements in gating methods, such as those
eported by Suzuki et al. (32), might prove useful
or coronary PET imaging.
tudy limitations. We observed that the coregistra-
ion and measurement process was highly reproduc-
ble within the ascending aorta, LM, proximal
AD, and proximal LCx, whereas measurements in
he RCA and in the mid- and distal coronary tree
ere substantially less reproducible. We posit that
he limited reproducibility in the RCA and the
istal coronary tree likely relates to the well-
escribed relative increase in coronary motion in
hose locations. Although efficiency in the coregis-
ration of images improved significantly with expe-
ience, the process remains time consuming and will
equire continued development before implementa-
ion outside of a research setting.
It is important to note that the inflammatory
ignal measured in our patients with ACS might
ot reflect the state of the signal just before the
linical presentation. Either the systemic inflamma-
ory milieu associated with the acute ACS, the
dditional inflammation associated with stenting,
r both might have contributed to the high PET
ignals that we measured in our patients with ACS
fter their stent implantations. It is possible that if
he ACS subjects were hypothetically imaged just
efore their events, the measurable vascular PET
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396table subjects. Ongoing studies examining the
mpact of therapies on the coronary PET signals
hould yield further insights. Moreover, natural
istory studies will be needed to evaluate whether
he aortic and coronary PET signals have clinical
tility.
ONCLUS IONS
he findings of this study show the feasibility of
DG imaging of the LM and that vascular activity
s increased in the aorta and LM of patients9. Phelps M. Positron emission tomog-
raphy provides molecular imaging of tions. J Nucl Med 2ncreased FDG uptake associated with culprit cor-
nary lesions in patients presenting with ACS.
ecause FDG uptake serves as an index of plaque
nflammation, this imaging approach may provide
nsights regarding the state of inflammation within
he coronary vasculature. These observations sup-
ort further efforts to refine PET methods to image
oronary plaque inflammation.
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